Login / Signup

Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.

Nadinda A M van der EndeBob RoozenbeekOlvert A BerkhemerPeter J KoudstaalJelis BoitenEwoud J van DijkYvo B W E M RoosRobert J Van OostenbruggeCharles B L M MajoieWim H van ZwamHester F LingsmaA V D LugtDiederik W J Dippelnull null
Published in: Stroke (2021)
URL: https://www.isrctn.com; Unique identifier: ISRCTN10888758.
Keyphrases
  • phase iii
  • placebo controlled
  • phase ii
  • double blind
  • study protocol
  • open label
  • clinical trial
  • atrial fibrillation
  • blood brain barrier